Tag Archives: Health Care

Implementing the WHO PIP Framework – Industry’s Role & Outlook

syringe

In May 2011, the World Health Organization (WHO) adopted the Pandemic Influenza Preparedness (PIP) Framework after nearly five years of contentious negotiations. As noted by Anne Huvos, WHO Secretariat, the two objectives of the PIP Framework are: (1) to improve sharing of influenza viruses with human pandemic potential; and (2) to achieve more predictable, efficient, and equitable access to benefits, such as vaccines and antiviral medicines, during future pandemics. The subject of a session at Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Analysis and Impact of PDUFA V

hamburg

As the House of Representatives voted unanimously to approve legislation to approve the Prescription Drug User Fee Act (PDUFA) V, industry leaders gathered at the 2012 BIO International Convention for a lively discussion on the changes the new legislation, focused on modernizing Food and Drug Administration regulations, will bring to the biotechnology industry. The super session panel discussion was moderated by Steve Usdin, Washington Editor of BioCentury and Co-Host of BioCentury This Week, and included Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Cancer Research Pioneer Dr. Margaret Foti named 2012 Biotech Humanitarian Honoree

Dr. Margaret Foti

Today, BIO named Dr. Margaret Foti, , Ph.D., M.D. (h.c.), CEO of the American Association of Cancer Research, as the 2012 Biotech Humanitarian Honoree.  Dr. Foti was honored for her tireless efforts to improve cancer research, her work as a cancer advocate and her ground-breaking work in the area of team science. Dr. Foti is also known for her work leading AACR’s scientific partnership with Stand Up To Cancer — a charitable initiative that supports Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

We Are BIO

Jim Greenwood

Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you to answer the question – What’s Your BIO? On behalf of the Biotechnology Industry Organization (BIO), I’d like to answer that question to illustrate how we advocate for federal, state and global policies to foster continued biotech breakthroughs, innovation and ingenuity. In addition to producing the BIO International Convention, we educate and engage public policy leaders in Washington, in state Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

BIO 2012 Super Session Recap: Ernst & Young’s Beyond Borders

Ernst & Young

The fanfare surrounding this morning’s unveiling of Ernst & Young’s 26th annual report on the state of the biotech industry, Beyond Borders, was buoyed by positive trends outlined in the report that show despite the overall lingering uneasiness in the economy, biotech is continuing its growth momentum. The Super Session at the 2012 BIO International Convention was moderated by members of Ernst & Young’s life sciences leadership team: Glen Giovannetti, Gautam Jaggi and Sanjeev Wadhwa; Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,